by Team Small News | Dec 5, 2025 | Pharma, Zydus
The U.S. Food and Drug Administration (FDA) has issued an Establishment Inspection Report (EIR) to Zydus Lifesciences, an injectable facility based in Vadodara, India. The report, which was issued with a Voluntary Action Indicated (VAI) classification, is a result of...
by Team Small News | Nov 28, 2025 | Pharma, Zydus
The Taliban-led government in Afghanistan has signed a significant trade agreement with Indian pharmaceutical company Zydus Lifesciences, marking a shift in the country’s trade posture. The $100 million memorandum of understanding was signed between...
by Team Small News | Nov 25, 2025 | Pharma, Zydus
Zydus, a pharmaceutical company, has introduced a new packaging innovation for its cough medication. The company has launched single-serve pouch packaging for its cough medication, making it more convenient and easy to use for consumers. This new packaging format is...
by Team Small News | Nov 12, 2025 | Glenmark, Pharma, Zydus
Zydus Lifesciences and Glenmark Pharmaceuticals have both received approvals from China’s National Medical Products Administration (NMPA) for their respective products. Zydus Lifesciences has been granted approval for Venlafaxine Extended-Release (ER) Capsules,...
by Team Small News | Nov 9, 2025 | Pharma, Zydus
Zydus Lifesciences Limited, an Indian pharmaceutical company, has received tentative approval from the United States Food and Drug Administration (USFDA) for its Olaparib Tablets, 100 mg and 150 mg. This medication is used to treat certain types of ovarian, breast,...
by Team Small News | Nov 4, 2025 | Pharma, Zydus
Zydus Lifesciences, a prominent pharmaceutical company, is facing a significant demand of Rs 74.23 crore from the Goods and Services Tax (GST) authorities. The company plans to challenge this order, indicating a potential dispute over the tax assessment. The GST...